Keywords: تکمیل عامل H; Atypical haemolytic uremic syndrome; Complement factor H; Postoperative period; Plasma exchange; SÃndrome urémico hemolÃtico atÃpico; Factor H del complemento; Periodo postoperatorio; Intercambio de plasma;
مقالات ISI تکمیل عامل H (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AREDS; Age-Related Eye Disease Study; CFH; Complement Factor H; CFI; Complement Factor I; CI; confidence interval; CNV; choroidal neovascularization; ECM; extracellular matrix; ETDRS; Early Treatment Diabetic Retino
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; ARMS2; age-related maculopathy susceptibility 2; BMES; Blue Mountains Eye Study; CFH; complement factor H; CI; confidence interval; OR; odds ratio; RS; Rotterdam Study; SNP; single nucleotide polymorphism; 3CC; Three
Keywords: تکمیل عامل H; aHUS; atypical hemolytic uremic syndrome; AP; alternative pathway; C3; complement component 3; C5; complement component 5; C3G; C3 glomerulopathy; CFB; complement factor B; CFH; complement factor H; CFI; complement factor I; COMS; complement serology pane
Keywords: تکمیل عامل H; Drusen; Sub-retinal pigment epithelial deposits; Mineral-protein interactions; Retinal disease; Quantitative proteomics; AMD; age-related macular degeneration; APOC4; apolipoprotein C4; BCA; bicinchoninic acid; C4A; complement factor C4A; C4B; complement
Keywords: تکمیل عامل H; C3GN; C3 glomerulonephritis; CFH; complement factor H; DDD; dense-deposit disease; MPGN; membranoproliferative glomerulonephritis;
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; ARMS2; Age Related Maculopathy Susceptibility 2; CFH; Complement Factor H; CI; confidence interval; D; diopter; IMT; intimal-medial thickness; MESA; Multi-Ethnic Study of Atherosclerosis; OR; odds ratio; SD; standa
Keywords: تکمیل عامل H; ANXA2; annexin A2; ANXA5; annexin A5; AUC; area under the curve; C1QB; complement component 1, q subcomponent, B chain; C5; complement component 5; CD46; complement regulatory protein; CDC; Centers for Disease Control and Prevention; CFH; complement facto
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AREDS; Age-Related Eye Diseases Study; ARMS2; age-related maculopathy susceptibility 2; BDES; Beaver Dam Eye Study; BMES; Blue Mountains Eye Study; CFH; complement factor H; CI; confidence interval; GA; geographic at
Keywords: تکمیل عامل H; A1AG1; α-1-acid glycoprotein; A2M; α-2-macroglobulin; A1AT; α-1-antitrypsin; ApoA-I; Apolipoprotein A-I; APOH; β-2-glycoprotein; CERU; ceruloplasmin; CD5L; CD5 antigen-like precursor; CFAB; complement factor B; CFAH; complement factor H; COPD; chronic
Keywords: تکمیل عامل H; Complement factor H; Neovascular; Age-related macular degeneration; Single nucleotide polymorphism
Keywords: تکمیل عامل H; Complement factor H; Polymorphism; Macular degeneration; Meta-analysis
SÃndrome urémico hemolÃtico atÃpico: una complicación postoperatoria infrecuente
Keywords: تکمیل عامل H; SÃndrome urémico hemolÃtico atÃpico; Factor H del complemento; Periodo postoperatorio; Intercambio de plasma; Atypical haemolytic uremic syndrome; Complement factor H; Postoperative period; Plasma exchange;
Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AREDS; Age-Related Eye Disease Study; ARMS2; age-related maculopathy susceptibility 2; BMI; body mass index; CFH; complement factor H; CI; confidence interval; df; degree of freedom; GTG; genotype group; indel; inser
miR-146 promotes HBV replication and expression by targeting ZEB2
Keywords: تکمیل عامل H; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; ZEB2; Zinc finger E-box-binding homeobox 2; IFN-α; interferon-α; NA; nucleotide analogues; miRNAs; microRNAs; CHB; chronic hepatitis B; CHORDC1; cysteine- and histidine-rich domain containing 1; FBS
Coding and Noncoding Variants in CFH Act Synergistically for Complement Activation in Immunoglobulin A Nephropathy
Keywords: تکمیل عامل H; Immunoglobulin A nephropathy; Complement factor H; Complement activation; Genetic variants;
Whole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch's Membrane
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; ARMS2; Age-Related Maculopathy Susceptibility 2; ANNOVAR; Annotate Variation; CADD; Combined Annotation Dependent Depletion; CFH; complement factor H; CFI; complement factor I; CMC; Combined Multivariate and Collaps
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
Keywords: تکمیل عامل H; AP; alternative pathway; C3G; C3 glomerulopathy; C3GN; C3 glomerulonephritis; C3Nef; C3 nephritic factor; C5Nef; C5 nephritic factor; CFB; complement factor B; CFH; complement factor H; CR; complete remission; DDD; dense deposit disease; eGFR; estimated g
Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration
Keywords: تکمیل عامل H; CFH; Complement Factor H; AMD; Age related macular degeneration; BM; Bruch's membrane; β2GPI; Beta-2-Glycoprotein I; TRX-1; Thioredoxin-1; TRX-R; Thioredoxin-1 reductase; NADPH; Nicotinamide adenine dinucleotide phosphate; MAA; Malondialdehyde acetaldehy
The complement factor H (CFH) and its related protein 2 (CFHR2) mediating immune response in large yellow croaker Larimichthys crocea
Keywords: تکمیل عامل H; Large yellow croaker; Complement factor H; CFH related gene; Molecular characterization; Functional analysis;
Serum starvation of ARPE-19 changes the cellular distribution of cholesterol and Fibulin3 in patterns reminiscent of age-related macular degeneration
Keywords: تکمیل عامل H; RPE; retinal pigment epithelium; UC; unesterified cholesterol; EC; esterified cholesterol; Fib3; EFEMP1/Fibulin3; AMD; age-related macular degeneration; ApoB; Apolipoprotein B; BrM; Bruch's membrane; HDL; high-density lipoprotein; FCS; fetal calf serum;
C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy
Keywords: تکمیل عامل H; C3 glomerulopathy; C5; C5a receptor; complement factor H; properdin;
Maternal plasma levels of complement Factor H in miscarriage and in normal pregnancy: A cohort study
Keywords: تکمیل عامل H; Complement Factor H; Early pregnancy; Miscarriage;
Fibulin-1 purification from human plasma using affinity chromatography on Factor H-Sepharose
Keywords: تکمیل عامل H; Fibulin-1; Complement Factor H; Human plasma; Purification; Affinity chromatographyAMD, Age related Macular Degeneration; cbEGF, calcium ion binding Epidermal Growth Factor (module); CIG, Cold Insoluble Globulin; ECM, Extracellular Matrix; EGF, Epidermal
Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration
Keywords: تکمیل عامل H; Age-related macular degeneration; Complement factor H; Eyebank tissue; Mitochondria; mtDNA; Haplogroups; Inflammation; Age-related macular degeneration; AMD; complement factor H; CFH; malondialdehyde; MDA; Minnesota Grading System; MGS; mitochondria; mt;
Collectin CL-P1 utilizes C-reactive protein for complement activation
Keywords: تکمیل عامل H; CRP; C-reactive protein; PTX3; pentraxin 3; CRD; carbohydrate recognition domain; Col; collagen; TCC; terminal complement complex; SR; scavenger receptor; CL-P1; collectin placenta 1; SR-AI; scavenger receptor type I; LOX-1; lectin-like oxidized LDL recep
Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AREDS; Age-Related Eye Disease Study; BM; Bruch's membrane; CFH; complement factor H; CFP; color fundus photography; CI; circularity index; EpM; Endpoint Management; FAF; fundus autofluorescence; GA; geographic atrop
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group
Keywords: تکمیل عامل H; ADAMTS13; a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13; AH50; complement alternate pathway assay; CH50; total hemolytic complement assay; CFB; complement factor B; CFHR1; complement factor H-related protein 1; CFI; com
Treatment Response to Antioxidants and Zinc Based on CFH and ARMS2 Genetic Risk Allele Number in the Age-Related Eye Disease Study
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AREDS; Age-Related Eye Disease Study; AREDS2; Age-Related Eye Disease Study 2; ARMS2; age-related maculopathy susceptibility 2; CFH; complement factor H; CI; confidence interval; GTG; genotype group; HR; hazard ratio
Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AREDS; Age-Related Eye Disease Study; ARMS2; age-related maculopathy susceptibility locus 2; CAREDS; Carotenoids in Age-Related Eye Disease Study; CFH; complement factor H; CFI; complement factor I; CI; confidence in
Chronic Central Serous Chorioretinopathy Is Associated with Genetic Variants Implicated in Age-Related Macular Degeneration
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AP; alternative complement pathway; CFH; complement factor H; cCSC; chronic central serous chorioretinopathy; CSC; central serous chorioretinopathy; EUGENDA; European Genetic Database; FA; fluorescein angiography; IC
Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration
Keywords: تکمیل عامل H; AE; adverse event; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CFH; complement factor H; CI; confidence interval; CNV; choroidal neovascularization; FA; fluorescein angiography; IR; intraretinal; IVT; intravitreal; OCT; opti
Association of Genetic Variants with Polypoidal Choroidal Vasculopathy
Keywords: تکمیل عامل H; ARMS2; age-related maculopathy susceptibility 2; CFH; complement factor H; CI; confidence interval; C2; complement component 2; HTRA1; high-temperature requirement factor A1; HWE; Hardy-Weinberg equilibrium; ICGA; indocyanine green angiography; nAMD; ne
Complement factor H and related proteins in age-related macular degeneration
Keywords: تکمیل عامل H; Age-related macular degeneration; Complement Factor H; Protective haplotypesDégénérescence maculaire liée à l’âge; Facteur complément H; Haplotypes protecteurs
An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator
Keywords: تکمیل عامل H; Complement factor H; Atypical haemolytic uremic syndrome; Anti-factor H autoantibodies; Complement factor I deficiency.FH, factor H; FI, factor I; aHUS, atypical haemolytic uremic syndrome; CFHRs, factor H related proteins
Identification and characterization of complement factor H in Branchiostoma belcheri
Keywords: تکمیل عامل H; CFH; complement factor H; cDNA; DNA complementary to RNA; bp; base pair(s); ORF; open reading frame; CCP; complement control protein; RT-PCR; reverse transcription-PCR; AmphiCFH; amphioxus complement factor H; C3-convertase; complement C3 convertase; C3a;
No Clinically Significant Association between CFH and ARMS2 Genotypes and Response to Nutritional Supplements
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; AREDS; Age-Related Eye Disease Study; ARMS2; age-related maculopathy susceptibility 2; CFH; complement factor H; df; degree of freedom; SNP; single nucleotide polymorphism;
Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: Implications for population susceptibility to diseases
Keywords: تکمیل عامل H; ABI; Applied Biosystems; ARPE-19; Retinal pigmented epithelium cell line; ATP; Adenosine triphosphate; CFH; Complement factor H; C1s; Complement component 1, s subcomponent; C3; Complement component 3; C4B; Complement component 4B; DMEM; Dulbecco's modifi
New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases
Keywords: تکمیل عامل H; Complement factor H related C; Dense deposit disease; Diabetes mellitus; Basal laminar deposits; Collagen-induced arthritis; Systemic lupus erythematosus; CP; classical pathway; AP; alternative pathway; LP; lectin pathway; MAC or C5b-9; membrane attack co
Review articleThe endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome
Keywords: تکمیل عامل H; Glycocalyx; Heparan sulfate proteoglycan; Complement factor H; Thrombomodulin; Atypical hemolytic uremic syndrome;
A method of purifying intact complement factor H from human plasma
Keywords: تکمیل عامل H; Complement factor H; Human plasma; Purification; Chromatography;
Regulation of the MIR155 host gene in physiological and pathological processes
Keywords: تکمیل عامل H; 3T3-L1; cell line derived from 3T3 cells; 3â²-UTR; 3â²-untranslated region; AICDA; activation-induced cytidine deaminase; AML; acute myeloid leukemia; Ang II; angiotensin II; AP-1; activator protein 1; AT1R; angiotensin II type 1 receptor; BACH1; basic
Genetic variation in complement regulators and susceptibility to age-related macular degeneration
Keywords: تکمیل عامل H; AMD; age-related macular degeneration; ARM; age-related maculopathy; CFB; complement factor B; CFH; complement factor H; CI; confidence interval; CPI; complement factor I; CFP; complement factor P; CNV; choroidal neovascularisation; DAF; decay acceleratin
Contribution of complement factor H Y402H polymorphism to sudden sensorineural hearing loss risk and possible interaction with diabetes
Keywords: تکمیل عامل H; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; CFH; complement factor H; CI; confidence interval; CRP; C-reactive protein; MPGN2; membranoproliferative glomerulonephritis type II; NILS-LSA; National Institute for Longevit
NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells
Keywords: تکمیل عامل H; 15-LOX; 15-lipoxygenase; AD; Alzheimer's disease; CFH; complement factor H; HNG; human neuronal-glial; LPS; lipopolysaccharide; miRNA; micro RNA; PDTC; pyrollidine dithiocarbamate; SYN-2; (SYN-II, synapsin-2); TNFα; tumor necrosis factor alpha; TSPAN-12;
Complement receptor 1 (CR1) and Alzheimer's disease
Keywords: تکمیل عامل H; AD; Alzheimer's disease; Aβ; amyloid-beta; ApoE; apolipoprotein E; BBB; blood-brain barrier; CCP; complement-control proteins; CFH; complement factor H; C3; complement factor 3; CR1; complement receptor 1; CSF; cerebrospinal fluid; E-CR1; erythrocyte c
Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance
Keywords: تکمیل عامل H; complement factor H; hemolytic uremic syndrome; disease-associated mutations
Retinal function and CFH-ARMS2 polymorphisms analysis: a pilot study in Italian AMD patients
Keywords: تکمیل عامل H; Age-related macular degeneration; Complement factor H; Early diagnosis; Electroretinography; Flicker sensitivity; Gene polymorphisms;
Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?
Keywords: تکمیل عامل H; HUS; haemolytic uraemic syndrome; TMA; thrombotic microangiopathy; ECs; endothelial cells; AP; alternative pathway; CP; classical pathway; MAC; membrane attack complex; CFH; complement factor H; SCRs; short consensus repeats; CFI; complement factor I; DAF
Chemical labelling of active serum thioester proteins for quantification
Keywords: تکمیل عامل H; C3; complement component 3; C3(H2O); C3 with hydrolysed thioester; C3(NH2NH2); hydrazine labelled C3; C3(bio); C3 labelled with biotin-PEG4-hydrazide; C3(N); C3 labelled with nucleophile at thioester bond; fI; complement factor I; fH; complement facto